about
Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitroLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution.Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery.Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.Enabling individualized therapy through nanotechnologyEndostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluationUSNCTAM perspectives on mechanics in medicine.Application of chitosan-based nanocarriers in tumor-targeted drug delivery.Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.Nanotechnology in dermatology.Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.Polysaccharide-Coated Magnetic Nanoparticles for Imaging and Gene Therapy.Biomedical Applications of Magnetically Functionalized Organic/Inorganic Hybrid Nanofibers.Engineering nanomedicines using stimuli-responsive biomaterials.Identifying fragilities in biochemical networks: robust performance analysis of Fas signaling-induced apoptosis.Lipid-based nanoparticles in cancer diagnosis and therapy.Application of nanotechnology in cancer.Silicon micro- and nanofabrication for medicineDelivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapyTargeted magnetic iron oxide nanoparticles for tumor imaging and therapy.Physical approaches to biomaterial design.Use of liposomes as drug delivery vehicles for treatment of melanoma.A new dawn for the use of traditional Chinese medicine in cancer therapy.Targeted drug delivery for treatment and imaging of glioblastoma multiforme.Gold nanoparticles in theranostic oncology: current state-of-the-art.Immunoconjugates and long circulating systems: origins, current state of the art and future directionsHighly fluorescent semiconducting polymer dots for biology and medicineThe application of nanosponges to cancer drug delivery.Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy.Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.A novel magnetic approach to enhance the efficacy of cell-based gene therapies.PEG-PBLG nanoparticle-mediated HSV-TK/GCV gene therapy for oral squamous cell carcinoma.Effects of As2O3 nanoparticles on cell growth and apoptosis of NB4 cells.Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.Cardiovascular nanomedicine: a posse ad esse.Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS®.
P2860
Q28476756-CCB71949-0B26-418E-8320-DB60473BBE7BQ30366990-9BE99344-BECB-440D-97C0-83A23725E072Q30524254-D299B109-16CA-4AC9-B031-0666D95BBF63Q33328294-662128A4-D2C5-46D4-863C-3461F4FEDC06Q33331602-AC7AA7AB-88FA-4C63-863F-862349EE1C0AQ33385557-A4357970-2706-42CE-A727-12336C29B3B8Q33630878-EFF18C96-6935-470F-B9F7-E6B21DA77F78Q33917755-97D154FD-4DD2-4FA0-94A0-FC14F928475AQ34396694-E1D3652C-0E61-4E14-B46B-E432726054F4Q34398830-E7105F01-AA1B-4115-9107-A2BA52F082F3Q34447152-BBDCBB27-F3D3-4F78-BD2D-95EA20BB0879Q35025058-DB1BA965-4BDE-4CA0-9D47-58879C6B183DQ35120307-F84542EA-A2C2-483C-AAE8-02FA8A423F4BQ35153705-75256CD2-C197-415D-84C8-41D27C283E37Q35674709-4A420AEC-693A-432F-AC1F-100E967DB432Q35814073-59DBCA24-6401-4AD2-A069-27F930ABD7A2Q36174884-AD8C2AE8-F2F5-43F3-BBB6-C155F0043A82Q36856453-A7BD8C3E-FAD0-4A4F-A4AA-3C0C41E0FC28Q37052002-4A68BCD0-78CF-4405-9B6C-C7C4FD26CFD1Q37111760-DC2EBFFF-6631-40E7-8431-485920FAE81FQ37184228-19C1D346-E700-495B-9E6C-201EFA9AFA31Q37194020-06654040-F759-4582-81CA-CD75DD997E79Q37319940-F430BA28-131E-49FC-AC31-DDC5E73ACBCCQ37354840-30176717-BE76-4485-B08A-934DAB30DE7FQ37406217-15010622-6FEC-42AE-B095-72662DCC644DQ37418257-53C109F1-6887-4469-9957-624D70531EC6Q37523966-1E2FDFFE-A31B-4041-857F-E0A04A8AA12BQ38035034-77381C66-455E-4CA0-90B9-D19B7979B826Q38042256-58FD53D0-3505-46DA-979A-C1264F66479BQ38073169-D4E8A7F8-DB79-4F9A-BA75-9014178C675CQ38210423-4AF2FEE2-3DB2-47E3-AF41-247FDBBA341CQ38557008-548700DB-89F0-4226-885C-E9F1A59FC133Q39451814-171536E7-B11A-4231-8856-39325D178523Q39575498-BD54436C-B134-43B2-A100-18F29C3D8E6AQ39991136-A9FC577B-88D4-412F-85B0-1D7BD2FF41E0Q40025984-7DE453A5-4B29-4C70-85D6-2E5D678FE397Q42585397-8727CD28-0623-4699-9D26-5024335C7B9AQ42658959-1C4B80C4-DD81-4189-AB13-E959C6C24D1BQ43232585-FD2C6054-298E-4B9A-9E13-C6E236A141AFQ51291038-C83B0648-768C-4767-8F9E-93F919AB69F3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Nanotechnology for targeted cancer therapy.
@en
type
label
Nanotechnology for targeted cancer therapy.
@en
prefLabel
Nanotechnology for targeted cancer therapy.
@en
P2093
P2860
P356
P1476
Nanotechnology for targeted cancer therapy.
@en
P2093
Dong M Shin
Jonathan W Simons
May D Wang
Shuming Nie
P2860
P304
P356
10.1586/14737140.7.6.833
P577
2007-06-01T00:00:00Z